| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |